{"schema_version":"alpha-profile-public-v1","slug":"matthew-gline-2","canonical_url":"https://registry.alpha.ac/people/matthew-gline-2","as_of":"2026-09-02T12:37:50.793824+00:00","published_at":"2026-09-02T02:37:21.319684+00:00","last_reviewed_at":"2026-05-15T20:25:44.885+00:00","identity":{"display_name":"Matthew Gline","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=matthew-gline-2","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=matthew-gline-2&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"roles":[],"claims":[{"claim_type":"ai_expertise","claim_value":{"detail":"Serves as the Chief Executive Officer and Director of Roivant Sciences.","ai_expertise":false},"claim_text":"SEC-derived executive row classified AI expertise as False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:25.128646+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.317063+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_governance_relevance","claim_value":{"reasons":["role_ceo"],"relevant":true},"claim_text":"AI-governance relevance classified as True from role/title and SEC-derived executive context.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:25.128646+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.317063+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Matthew Gline as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:03:22.673283+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-14T23:03:22.526397+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Matthew Gline as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:25:45.0541+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-15T20:25:44.937246+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"ROIV","role_type":"Director","organization":"Roivant Sciences"},"claim_text":"Serves on the board of Roivant Sciences as Director.","claim_state":"verified","valid_from":"2021-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.447636+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Matthew Gline currently serves as Director at Arbutus Biopharma Corp.","claim_state":"verified","valid_from":"2026-04-14","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:25:45.012554+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-15T20:25:44.937246+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Matthew Gline currently serves as Director at Roivant Sciences.","claim_state":"verified","valid_from":"2025-07-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:49.66038+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:49.585789+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Matthew Gline serves on no disclosed committees.","claim_state":"verified","valid_from":"2026-04-14","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:25:45.03656+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-15T20:25:44.937246+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Matthew Gline serves on no disclosed committees.","claim_state":"verified","valid_from":"2025-07-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:49.681951+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:49.585789+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Roivant Sciences","claim_text":"Matthew Gline is linked to Roivant Sciences as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:49.812244+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:49.585789+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"Matthew Gline is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:49.791961+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:49.585789+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Matthew Gline as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:03:22.709574+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-14T23:03:22.526397+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Matthew Gline as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:25:45.102794+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-15T20:25:44.937246+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2021},"claim_text":"Director tenure at Roivant Sciences begins from 2021.","claim_state":"verified","valid_from":"2021-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.447636+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Arbutus Biopharma Corp","claim_text":"Matthew Gline is associated with Arbutus Biopharma Corp.","claim_state":"verified","valid_from":"2026-04-14","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:03:22.656114+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-14T23:03:22.526397+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Roivant Sciences","claim_text":"Matthew Gline is associated with Roivant Sciences.","claim_state":"verified","valid_from":"2025-07-29","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:33.651793+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:33.442676+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":{"ticker":"ROIV","company":"Roivant Sciences"},"claim_text":"Matthew Gline is associated with Roivant Sciences.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:25.128646+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.317063+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_function","claim_value":{"role_family":"enterprise_leadership","role_type_normalized":"ceo"},"claim_text":"Matthew Gline maps to the enterprise leadership executive function.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:25.128646+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.317063+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Director","claim_text":"Matthew Gline is listed as Director at Arbutus Biopharma Corp.","claim_state":"verified","valid_from":"2026-04-14","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:03:22.636365+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-14T23:03:22.526397+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Chief Executive Officer and Director","claim_text":"Matthew Gline is listed as Chief Executive Officer and Director at Roivant Sciences.","claim_state":"verified","valid_from":"2025-07-29","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-06T06:25:33.622518+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-06T06:25:33.442676+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":{"title":"Chief Executive Officer and Director","role_type_normalized":"ceo"},"claim_text":"Matthew Gline is listed as Chief Executive Officer and Director at Roivant Sciences.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T15:43:25.128646+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ROIV executive roster source","source_type":"sec_filing","source_tier":3,"source_url":null,"published_at":null,"last_checked_at":"2026-05-03T15:42:45.317063+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":false},"claim_text":"Board independence status at Roivant Sciences: False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.447636+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Roivant Sciences director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","published_at":"2025-07-29T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:44.926776+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Chief Executive Officer","company":"Roivant Sciences"},"claim_text":"Matthew Gline is also linked to Roivant Sciences as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:03:22.743996+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-14T23:03:22.526397+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Matthew Gline as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:25:45.079733+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-15T20:25:44.937246+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":true,"claim_text":"Executive extraction classified technology background for Matthew Gline as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-14T23:03:22.692081+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ABUS DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","published_at":"2026-04-14T00:00:00+00:00","last_checked_at":"2026-05-14T23:03:22.526397+00:00","relation":"supports","excerpt_locator":null}]}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/matthew-gline-2#profile","url":"https://registry.alpha.ac/people/matthew-gline-2","dateModified":"2026-05-15T20:25:44.885+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/matthew-gline-2#person","name":"Matthew Gline","url":"https://registry.alpha.ac/people/matthew-gline-2"},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036126014623/ny20065142x1_def14a.htm","name":"ABUS DEF 14A executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125027846/ny20049997x1_def14a.htm","name":"Roivant Sciences director board source"}],"mainEntityOfPage":"https://registry.alpha.ac/people/matthew-gline-2"},"presentation":null,"presentation_authority":"not_published","trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":6,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":17,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":6,"distinct_source_count":3,"conflicts":[{"claim_type":"technology_background","kind":"extraction_disagreement","headline":false,"review_route":"internal_review","values":["false","true"],"publishers":["SEC EDGAR"],"source_types":["sec_filing"],"rationale":"Pipeline extraction runs disagree over documents from one publisher; routed to internal review, not headlined."}],"conflict_count":1,"headline_conflict_count":0,"internal_review_conflict_count":1,"contradiction_types":["technology_background"],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":6,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":17,"corroborated_claims":6,"sources":6,"distinct_sources":3,"role_claims":0,"last_reviewed_at":"2026-05-15T20:25:44.885+00:00","observed_at":"2026-09-02T12:37:50.793824+00:00","freshness_days":110}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"matthew-gline-2","canonical_url":"https://registry.alpha.ac/people/matthew-gline-2"},"publication":{"published_at":"2026-09-02T02:37:21.319684+00:00","last_reviewed_at":"2026-05-15T20:25:44.885+00:00","as_of":"2026-09-02T12:37:50.793824+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/matthew-gline-2","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/matthew-gline-2","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/matthew-gline-2.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}